Possibilities of predicting adverse cardiovascular events based on the analysis of clinical and instrumental research methods, as well as sST2 in patients after myocardial infarction.

Autor: Volynskyi DA; IVANO-FRANKIVSK NATIONAL MEDICAL UNIVERSITY, IVANO-FRANKIVSK, UKRAINE., Vakaliuk IP; IVANO-FRANKIVSK NATIONAL MEDICAL UNIVERSITY, IVANO-FRANKIVSK, UKRAINE., Tymochko NB; IVANO-FRANKIVSK NATIONAL MEDICAL UNIVERSITY, IVANO-FRANKIVSK, UKRAINE., Zvonar PP; IVANO-FRANKIVSK NATIONAL MEDICAL UNIVERSITY, IVANO-FRANKIVSK, UKRAINE.

Publikováno v: Wiadomosci lekarskie (Warsaw, Poland : 1960) [Wiad Lek] 2024; Vol. 77 (2), pp. 305-310.

MARKER DIAGNOSTIC HEART FAILURE PROGRESSION IN THE POST-INFARCTION PERIOD.

Autor: Levandovska KV; IVANO-FRANKIVSK NATIONAL MEDICAL UNIVERSITY, IVANO-FRANKIVSK, UKRAINE., Vakaliuk IP; IVANO-FRANKIVSK NATIONAL MEDICAL UNIVERSITY, IVANO-FRANKIVSK, UKRAINE., Naluzhna TV; IVANO-FRANKIVSK NATIONAL MEDICAL UNIVERSITY, IVANO-FRANKIVSK, UKRAINE.

Publikováno v: Wiadomosci lekarskie (Warsaw, Poland : 1960) [Wiad Lek] 2022; Vol. 75 (10), pp. 2476-2480.

Management of Dyslipidemia in Individuals with Low-to-Moderate Cardiovascular Risk: Role of Nutraceuticals.

Autor: Dolzhenko MM; The Cardiology Department, The Shupyk National Medical Academy of Postgraduate Education, Dorogozhytska St., 9, Kyiv, 04112, Ukraine. marynadolzhenko@gmail.com., Barnett OY; Department of Therapy № 1 of Medical Diagnostics, Hematology and Transfusiology, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine., Grassos C; The Cardiology Department, General Hospital of Attica 'KAT', Kifissia, Greece., Dragomiretska NV; The Medical Rehabilitation Department, SI 'Ukrainian Scientific-Research Institute of Medical Rehabilitation and Balneology of the Ministry of Health of Ukraine', Kiev, Ukraine., Goloborodko BI; The Cardiology Department, ODREX Medical Home, Rozkidaylivska Street, 69/71, Odesa, 65080, Ukraine., Ilashchuk TO; The Propedeutics of Internal Diseases Department, Higher State Educational Establishment of Ukraine 'Bukovinian State Medical University', Chernivtsi, Ukraine., Zuiev KO; The General Endocrine Pathology and Metabolism Department, Kyiv Municipal Endocrine Center, Kiev, Ukraine., Karpenko OV; Department of propedeutics of internal medicine № 2, Bohomolets National Medical University, Kiev, Ukraine., Kolesnikova OV; Aging and the Metabolic Associated Diseases Prevention Research Department, Government Institution 'L.T. Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine', Kharkiv, Ukraine., Kolesnyk TV; The Department of Internal Medicine Propedeutics, State Institution 'Dnipropetrovsk Medical Academy' of the Ministry of Health of Ukraine, Dnipro, Ukraine., Talaieva TV; The Department of Clinical Physiology and Genetics, National Scientific Center, M.D. Strazhesko Institute of Cardiology, Kiev, Ukraine., Vakaliuk IP; The Department of Internal Medicine No. 2 and Nursing, State Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine., Tiabut TD; The Cardiology and Rheumatology Department, Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus., Mesnikova IL; Polyclinic Therapy Department, Belarusian State Medical University, Minsk, Belarus., Zinych OV; The Age Endocrinology and Clinical Pharmacology Department, State Institution V.P. Komisarenko Institute of Endocrinology and Metabolism of NAMS of Ukraine, Kiev, Ukraine.

Publikováno v: Advances in therapy [Adv Ther] 2020 Nov; Vol. 37 (11), pp. 4549-4567. Date of Electronic Publication: 2020 Sep 26.

[Characteristics of medical use of Korvazan® for restorative treatment of patients with myocardial infarction, counting the risk factors].

Autor: Vakaliuk IP, Tymochko NB

Publikováno v: Likars'ka sprava [Lik Sprava] 2013 Dec (8), pp. 94-9.

[The use of finoptin and alpha-tocopherol in patients with stable exertional stenocardia].

Autor: Levchenko VA, Serediuk NN, Gereliuk IP, Vakaliuk IP, Bondar' MM

Publikováno v: Vrachebnoe delo [Vrach Delo] 1990 Jan (1), pp. 61-4.